先看重点
在24项随机试验、共8933名参与者中,移动健康(mHealth)自我管理使收缩压比对照组多降低3.78 mm Hg,舒张压多降低1.57 mm Hg。所有研究均被评为高偏倚风险,效应可能被高估。
证据类型
证据综述
解读依据
公开摘要
阅读重点
方法与适用范围
研究在问什么
高血压需要认真的自我管理,移动技术也越来越多地用于支持这一点。研究者汇总了面向成人高血压患者的mHealth试验,考察血压、血压控制、服药依从性、自我管理行为和费用。
研究了谁,如何研究
系统评价和荟萃分析,并辅以叙述性综合。检索5个电子数据库及参考文献列表,纳入2010年1月至2019年9月间发表的同行评议随机对照试验。3名研究者独立提取数据并评估质量。共纳入24项研究、8933名参与者:23项报告了血压,12项提供了收缩压(SBP)和舒张压(DBP)数据用于荟萃分析,16项报告了行为改变和依从性。已在PROSPERO注册(CRD42019152062)。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1mHealth组的SBP下降幅度大于对照组,为-3.78 mm Hg(P<.001;95%置信区间-4.67至-2.89),DBP为-1.57 mm Hg(P<.001;95%置信区间-2.28至-0.86)。
- 2按提醒频率、互动方式、干预功能和研究持续时间分层的亚组中,血压降低的结果一致。
- 316项研究报告干预组服药依从性和行为改善更好,8项显示无显著变化。
- 46项研究包含经济学评价,结论不一致,但都提到了潜在的长期经济收益。最成功的mHealth干预结合了个性化信息、互动沟通和多种功能。
局限与不确定性
- 1所有研究均被评估为高偏倚风险,这会夸大表观获益。
- 224项研究中只有12项纳入血压荟萃分析,摘要也未报告异质性。
- 3摘要未说明使用了哪些应用或设备,作者也呼吁开展更长时间的试验并进行文化适应。本文解读仅基于摘要。
对日常健康的启示
带有个性化、互动信息和多种功能的手机项目,与血压小幅下降相关,幅度类似某些小的生活方式改变。由于这些试验全部为高偏倚风险,应把结果看作有希望而非定论。降压药物和血压目标应由临床医生与你共同确定。
如何联系自己的数据
这与家庭血压监测直接相关:使用经验证的血压计,每天在相同时间、坐位休息后测量,并在应用中记录。比较每周平均值,把记录交给临床医生,而不是对单次读数作出反应。
如何理解这类证据
先看纳入了哪些设计、检索与偏倚评估如何完成,以及检索截止日期;发表新不代表底层证据都是最新的。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Effective treatment of hypertension requires careful self-management. With the ongoing development of mobile technologies and the scarcity of health care resources, mobile health (mHealth)-based self-management has become a useful treatment for hypertension, and its effectiveness has been assessed in many trials. However, there is a paucity of comprehensive summaries of the studies using both qualitative and quantitative methods.
Objective
This systematic review aimed to measure the effectiveness of mHealth in improving the self-management of hypertension for adults. The outcome measures were blood pressure (BP), BP control, medication adherence, self-management behavior, and costs.
Methods
A systematic search was conducted using 5 electronic databases. The snowballing method was used to scan the reference lists of relevant studies. Only peer-reviewed randomized controlled trials (RCTs) published between January 2010 and September 2019 were included. Data extraction and quality assessment were performed by 3 researchers independently, adhering to the validation guideline and checklist. Both a meta-analysis and a narrative synthesis were carried out.
Results
A total of 24 studies with 8933 participants were included. Of these, 23 studies reported the clinical outcome of BP, 12 of these provided systolic blood pressure (SBP) and diastolic blood pressure (DBP) data, and 16 articles focused on change in self-management behavior and medication adherence. All 24 studies were included in the narrative synthesis. According to the meta-analysis, a greater reduction in both SBP and DBP was observed in the mHealth intervention groups compared with control groups, -3.78 mm Hg (P<.001; 95% CI -4.67 to -2.89) and -1.57 mm Hg (P<.001; 95% CI -2.28 to -0.86), respectively. Subgroup analyses showed consistent reductions in SBP and DBP across different frequencies of reminders, interactive patterns, intervention functions, and study duration subgroups. A total of 16 studies reported better medication adherence and behavioral change in the intervention groups, while 8 showed no significant change. Six studies included an economic evaluation, which drew inconsistent conclusions. However, potentially long-term financial benefits were mentioned in all economic evaluations. All studies were assessed to be at high risk of bias.
Conclusions
This review found that mHealth self-management interventions were effective in BP control. The outcomes of this review showed improvements in self-management behavior and medication adherence. The most successful mHealth intervention combined the feature of tailored messages, interactive communication, and multifaceted functions. Further research with longer duration and cultural adaptation is necessary. With increasing disease burden from hypertension globally, mHealth offers a potentially effective method for self-management and control of BP. mHealth can be easily integrated into existing health care systems.
Trial registration
PROSPERO CRD42019152062; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=152062.
来源与署名
The Effectiveness of Self-Management of Hypertension in Adults Using Mobile Health: Systematic Review and Meta-Analysis.
Li R, Liang N, Bu F, Hesketh T.
JMIR mHealth and uHealth · 2020-03-27
DOI: 10.2196/17776 ↗PubMed · 32217503 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
昼夜活动节律紊乱与更高的死亡风险相关(109,365人)
在7项观察性研究、共109,365名参与者中,昼夜活动对比较弱(相对振幅较低)与更高的心血管死亡风险(风险比[HR]1.50,95%置信区间1.13至1.98)和全因死亡风险(HR 1.46,95%置信区间1.27至1.68)相关。证据基础小,又是观察性的,不能说明改善节律就能降低风险,疾病本身也可能扰乱节律。
Journal of the American Heart Association
五类运动都降低了静息血压,等长训练降幅最大
汇总270项随机试验、共15,827名参与者的结果,有氧、抗阻、联合、间歇和等长训练与无干预对照组相比都降低了静息血压(各P<0.001),其中等长训练降幅最大:收缩压下降8.24 mm Hg,舒张压下降4.00 mm Hg。各方式之间的排序部分来自间接比较,各试验也不尽相同,所以排序不是个人的运动处方。
British Journal of Sports Medicine
盐替代品使中国农村高危人群的卒中、主要心血管事件和死亡率下降
在中国农村600个村庄、20,995名有卒中史或年龄在60岁及以上且有高血压的人中,使用盐替代品(氯化钠75%、氯化钾25%)的卒中发生率低于普通盐:平均随访4.74年,每1000人年29.14次对33.65次(率比0.86,95%置信区间0.77至0.96;P=0.006)。死亡也更低(率比0.88),严重高钾血症事件没有显著增多,但试验为开放标签设计,且在中国农村开展。
The New England Journal of Medicine
智能手表脉搏不规则提醒较少见,做贴片检查者34%确有房颤
在419,297名没有已知心房颤动(房颤)的苹果手表用户中,0.52%收到脉搏不规则提醒;返还可用心电贴片的450人中,34%确认有房颤(97.5%置信区间29至39)。提醒发出时恰有贴片记录的,通知的阳性预测值为0.84(95%置信区间0.76至0.92),但收到提醒者中仅20.8%返还了贴片,没有收到提醒的人未被监测,所以手表没有提醒并不能排除房颤。
The New England Journal of Medicine

